Literature DB >> 29978353

Complex PCI procedures: challenges for the interventional cardiologist.

Nikos Werner1, Georg Nickenig2, Jan-Malte Sinning2.   

Abstract

In recent years, the percentage of patients with multivessel disease and multiple complex stenoses have significantly increased. One factor contributing to this increase is the proportion of elderly and very elderly patients who have been turned down by the Heart Team for surgical revascularization (Landes et al. in Catheter Cardiovasc Interv, https://doi.org/10.1002/ccd.27375 , 2017; Waldo et al. in Circulation 130:2295-2301, https://doi.org/10.1161/CIRCULATIONAHA.114.011541 , 2014). In addition, the marked increase in patients with significant comorbidities further contributes to the increase in patients referred to the interventional cardiologist for stenting procedures. Mostly, the complexity of these patients is characterized not only by their comorbidities but also by multivessel disease, bifurcation disease, left main disease, or stenoses of calcified or tortuous vessels, degenerated saphenous vein graft lesions, and thrombotic lesions (Kirtane et al. in Circulation 134:422-431, 2016; Gennaro Giustino et al. in JACC 86:1851-1864, 2016) These specific lesion types are typically associated with lower rates of procedural success and higher rates of recurrence or major adverse cardiac events (Kirtane et al. 2016) Coming along with this problem, virtually no study exists evaluating revascularization strategies, i.e. percutaneous coronary intervention (PCI), coronary artery bypass graft surgery, or medical therapy alone in complex patients with complex coronary anatomy. Therefore, we are confronted with an increasing patient population that is understudied and potentially underserved. In the absence of robust, accurate, objective, and consistent evidence which could help us in decision-making (e.g. best revascularization strategy, complication prevention, post-interventional medical therapy), we have to stick to personal experience and patients' preferences. In this article, we provide an overview about common definition of complex PCI, general strategies to help decision-making in these patients, and give an overview about post-interventional medical treatment.

Entities:  

Keywords:  PCI procedures

Mesh:

Year:  2018        PMID: 29978353     DOI: 10.1007/s00392-018-1316-1

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  35 in total

1.  Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study.

Authors:  Kenichi Fujii; Stéphane G Carlier; Gary S Mintz; Yi-ming Yang; Issam Moussa; Giora Weisz; George Dangas; Roxana Mehran; Alexandra J Lansky; Edward M Kreps; Michael Collins; Gregg W Stone; Jeffrey W Moses; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

2.  Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy.

Authors:  Yong Liu; Ji-Yan Chen; Ning Tan; Ying-Ling Zhou; Dan-Qing Yu; Zhu-Jun Chen; Yi-Ting He; Yuan-Hui Liu; Jian-Fang Luo; Wen-Hui Huang; Guang Li; Peng-Cheng He; Jun-Qing Yang; Nian-Jin Xie; Xiao-Qi Liu; Da-Hao Yang; Shui-Jin Huang; Hua-Long Li; Peng Ran; Chong-Yang Duan; Ping-Yan Chen
Journal:  Circ Cardiovasc Interv       Date:  2015-06       Impact factor: 6.546

3.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

4.  The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial.

Authors:  Vasim Farooq; Patrick W Serruys; Hector M Garcia-Garcia; Yaojun Zhang; Christos V Bourantas; David R Holmes; Michael Mack; Ted Feldman; Marie-Claude Morice; Elisabeth Ståhle; Stefan James; Antonio Colombo; Roberto Diletti; Michail I Papafaklis; Ton de Vries; Marie-Angèle Morel; Gerrit Anne van Es; Friedrich W Mohr; Keith D Dawkins; Arie-Pieter Kappetein; Georgios Sianos; Eric Boersma
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

5.  Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis.

Authors:  Seung-Jung Park; Jung-Min Ahn; Soo-Jin Kang; Sung-Han Yoon; Bon-Kwon Koo; Jong-Young Lee; Won-Jang Kim; Duk-Woo Park; Seung-Whan Lee; Young-Hak Kim; Cheol Whan Lee; Seong-Wook Park
Journal:  JACC Cardiovasc Interv       Date:  2014-08       Impact factor: 11.195

6.  Intravascular Ultrasound Guidance Is Associated With Better Outcome in Patients Undergoing Unprotected Left Main Coronary Artery Stenting Compared With Angiography Guidance Alone.

Authors:  Pontus Andell; Sofia Karlsson; Moman A Mohammad; Matthias Götberg; Stefan James; Jens Jensen; Ole Fröbert; Oskar Angerås; Johan Nilsson; Elmir Omerovic; Bo Lagerqvist; Jonas Persson; Sasha Koul; David Erlinge
Journal:  Circ Cardiovasc Interv       Date:  2017-05       Impact factor: 6.546

7.  Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation.

Authors:  Pim A L Tonino; William F Fearon; Bernard De Bruyne; Keith G Oldroyd; Massoud A Leesar; Peter N Ver Lee; Philip A Maccarthy; Marcel Van't Veer; Nico H J Pijls
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

8.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

9.  Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study.

Authors:  Jaya Chandrasekhar; Usman Baber; Samantha Sartori; Melissa Aquino; Annapoorna S Kini; Sunil Rao; William Weintraub; Timothy D Henry; Serdar Farhan; Birgit Vogel; Sabato Sorrentino; Zhen Ge; Samir Kapadia; Joseph B Muhlestein; Sandra Weiss; Craig Strauss; Catalin Toma; Anthony DeFranco; Mark B Effron; Stuart Keller; Brian A Baker; Stuart Pocock; George Dangas; Roxana Mehran
Journal:  Can J Cardiol       Date:  2017-12-27       Impact factor: 5.223

10.  Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.

Authors:  Javier Escaned; Carlos Collet; Nicola Ryan; Giovanni Luigi De Maria; Simon Walsh; Manel Sabate; Justin Davies; Maciej Lesiak; Raul Moreno; Ignacio Cruz-Gonzalez; Stephan P Hoole; Nick Ej West; J J Piek; Azfar Zaman; Farzin Fath-Ordoubadi; Rodney H Stables; Clare Appleby; Nicolas van Mieghem; Robert Jm van Geuns; Neal Uren; Javier Zueco; Pawel Buszman; Andres Iñiguez; Javier Goicolea; David Hildick-Smith; Andrzej Ochala; Dariusz Dudek; Colm Hanratty; Rafael Cavalcante; Arie Pieter Kappetein; David P Taggart; Gerrit-Anne van Es; Marie-Angèle Morel; Ton de Vries; Yoshinobu Onuma; Vasim Farooq; Patrick W Serruys; Adrian P Banning
Journal:  Eur Heart J       Date:  2017-11-07       Impact factor: 29.983

View more
  11 in total

1.  Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis.

Authors:  Erion Xhepa; Robert A Byrne; Fernando Rivero; Andi Rroku; Javier Cuesta; Gjin Ndrepepa; Sebastian Kufner; Teresa Bastante Valiente; Salvatore Cassese; Marcos Garcia-Guimaraes; Anna Lena Lahmann; Himanshu Rai; Heribert Schunkert; Michael Joner; María José Pérez-Vizcayno; Nieves Gonzalo; Fernando Alfonso; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2019-02-19       Impact factor: 5.460

2.  Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions.

Authors:  Ming Bai; Andong Lu; Chenliang Pan; Sixiong Hu; Wenjing Qu; Jing Zhao; Bo Zhang
Journal:  Front Med (Lausanne)       Date:  2022-05-26

3.  The interventionist mindset: The ten eyes rule in cath lab.

Authors:  Ameen Mosa Mohammad
Journal:  Ann Med Surg (Lond)       Date:  2020-11-28

4.  A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation.

Authors:  Alper Öner; Caroline Moerke; Anne Wolff; Sabine Kischkel; Wolfram Schmidt; Niels Grabow; Hüseyin Ince
Journal:  Eur J Med Res       Date:  2020-07-29       Impact factor: 2.175

5.  Noncalcified plaque burden quantified from coronary computed tomography angiography improves prediction of side branch occlusion after main vessel stenting in bifurcation lesions: results from the CT-PRECISION registry.

Authors:  Kajetan Grodecki; Sebastien Cadet; Adam D Staruch; Anna M Michalowska; Cezary Kepka; Rafal Wolny; Jerzy Pregowski; Mariusz Kruk; Mariusz Debski; Artur Debski; Ilona Michalowska; Piotr J Slomka; Adam Witkowski; Damini Dey; Maksymilian P Opolski
Journal:  Clin Res Cardiol       Date:  2020-05-08       Impact factor: 5.460

6.  Walking the Line with Ticagrelor: Meta-Analysis Comparing the Safety and Efficacy of Ticagrelor Monotherapy after a Short Course of Ticagrelor-Based Dual Antiplatelet Therapy versus Standard Therapy in Complex Percutaneous Coronary Intervention.

Authors:  Francesco Condello; Matteo Sturla; Riccardo Terzi; Alberto Polimeni; Giulio G Stefanini
Journal:  J Clin Med       Date:  2021-11-24       Impact factor: 4.241

7.  Safety and efficacy of immediate heparin reversal with protamine after complex percutaneous coronary intervention.

Authors:  Jin Hee Choi; Kook Jin Chun; Soon Myung Jung; Soo Yong Lee; Min Ku Chon; Sang Hyun Lee; Ki Won Hwang; Jeong Su Kim; Yong-Hyun Park; June Hong Kim
Journal:  BMC Cardiovasc Disord       Date:  2022-05-10       Impact factor: 2.298

8.  Impact of left-ventricular end-diastolic pressure as a predictor of periprocedural hemodynamic deterioration in patients undergoing Impella supported high-risk percutaneous coronary interventions.

Authors:  Fadi Al-Rashid; Amir A Mahabadi; Laura Johannsen; Julian Soldat; Iryna Dykun; Rolf Alexander Jánosi; Matthias Totzeck; Tienush Rassaf
Journal:  Int J Cardiol Heart Vasc       Date:  2019-11-26

9.  Potential Protective Effect of Vitamin C on Qunalphos-Induced Cardiac Toxicity: Histological and Tissue Biomarker Assay.

Authors:  Ayed A Shati; Mohamed Samir A Zaki; Youssef A Alqahtani; Mohamed A Haidara; Mubarak Al-Shraim; Amal F Dawood; Refaat A Eid
Journal:  Biomedicines       Date:  2021-12-24

10.  Is a novel diagnostic pathway for cardiology outpatient clinics in Singapore lower cost than existing practice: a cost modelling study.

Authors:  Huang Weiting; Gaya Karthik; Terrance Chua; Nicholas Graves
Journal:  BMJ Open       Date:  2022-02-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.